All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99


The Effect of Chitooligosaccharides on Gut Microbiota in Diabetic Mice

DOI: 10.4236/oalib.1105961, PP. 1-5

Subject Areas: Diabetes & Endocrinology

Keywords: Diabetes, Chitooligosaccharides, High-Throughput Sequencing, Gut Microbiota

Full-Text   Cite this paper   Add to My Lib


Chitooligosaccharides (COS) has an effect to reduce blood glucose and blood lipids and is used in adjuvant therapy for diabetes mellitus (DM), which is closely associated with gut microbiota. Therefore, it is worthy investigating whether COS exerts its effect via the gut microbiota. In this paper, we studied the response of gut microbiota in diabetic mice to COS, using the high-throughput sequencing technology. We found that COS had significant effect on the community structure of gut microbiota in mice though it had no significant effect on the α-diversity of gut microbiota; the abundance of Ac-tinobacteria was increased significantly in the gut tract of mice fed with COS (P < 0.05); the abundance of Corynebacteriaceae significantly increased in di-abetic mice fed with COS (P < 0.05); at OTU level, the abundance of 13 OTUs of Bacteroidales S24-7 group decreased significantly (P < 0.05) while that of Lachnospiraceae increased significantly (P < 0.05) in diabetic mice intra-gastrically administered with COS. The results of our experiment suggest that the effect of COS to reduce blood glucose in diabetic mice might be produced by decreasing the abundance of Bacteroidetes and increasing that of Firmicutes and Actinobacteria.

Cite this paper

Wang, X. , Hu, Q. and Dong, C. (2019). The Effect of Chitooligosaccharides on Gut Microbiota in Diabetic Mice. Open Access Library Journal, 6, e5961. doi:


[1]  Kostic, A.D., Xavier, R.J. and Gevers, D. (2014) The Microbiome in Inflammatory Bowel Diseases: Current Status and the Future Ahead. Gastroenterology, 146, 1489-1499.
[2]  Wang, T., Cai, G., Qiu, Y., et al. (2012) Structural Segregation of Gut Microbiota between Colorectal Cancer Patients and Healthy Volunteers. The ISME Journal, 6, 320-329.
[3]  Fei, N. and Zhao, L. (2013) An Opportunistic Pathogen Isolated from the Gut of an Obese Human Causes Obesity in Germfree Mice. The ISME Journal, 7, 880-884.
[4]  Arthur, J.C., Perez-Chanona, E., Muhlbauer, M., et al. (2012) Gut Inflammation Targets Cancer-Inducing Activity of the Microbiota. Science, 338, 120-123.
[5]  Backhed, F., Ley, R.E., Sonnenburg, J.L., et al. (2005) Host-Bacterial Mutualism in the Human Intestine. Science, 307, 1915-1920.
[6]  Eckburg, P.B., Bik, E.M., Bernstein, C.N., et al. (2005) Diversity of the Human Gut Microbial Flora. Science, 308, 1635-1538.
[7]  Larsen, N., Vogensen, F.K., Berg, F.W., et al. (2010) Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults. PLoS ONE, 5, e9085.
[8]  Wang, Z.H., Jiang, Y.Y., Yu, X.H., et al. (2016) The Effect of Chitin and Its Water Soluble Derivatives on Immunity Function of Mice. Chinese Food Science, 37, 198-202.
[9]  Oey, I., Verlinde, P., Hendnickx, M., et al. (2006) Temperature and Pressure Stability of L-Ascorbic Acid and/or [6s]-5-Methyltetrahydrofolic Acid: A Kinetic Study. European Food Research and Technology, 223, 71-77.
[10]  Ni, T.Q. and Hu, S.Y. (2012) Progress of Research on the Pharmacological Effect and Clinical Application of Chitin and Its Derivative Chitosan. Drugs and Clinic, 27, 313-316.
[11]  Wang, M.R., Yao, P. and Zhang, B. (2014) The Effect of Chitooligosaccharides on the Blood Glucose and Gut Microbiota of Mice with Diabetes Caused by Streptozocin-STZ. Chinese Journal of Biochemical Pharmaceutics, 34, 72-74.
[12]  Terada, A., Hara, H., Sato, D., et al. (1995) Effect of Dietary Chitosan on Faecal Microbiota and Faecal Metabolites of Humans. Microbial Ecology in Health and Disease, 8, 15-21.
[13]  Mrazek, J., Koppova, I., Kopecny, J., et al. (2010) PCR-DGGE-Based Study of Fecal Microbial Stability during the Long-Term Chitosan Supplementation of Humans. Folia Microbiologica, 55, 352-358.
[14]  Azuma, K., Izumi, R., Kawata, M., et al. (2015) Effects of Oral Administration of Chitin Nanofiber on Plasma Metabolites and Gut Microorganisms. International Journal of Molecular Sciences, 16, 21931-21949.
[15]  Chen, J.G., Mei, S., Fu, Y., et al. (2004) Study on Normal Reference Value of Fasting Blood Glucose in ICR Mice. Journal of Health Toxicology, No. 1, 61. (In Chinese)
[16]  Ren, L., Li, B.L., Gao, S.Y., et al. (2001) Effects of Chitooligosaccharides on Blood Glucose and Intestinal Flora in Diabetic Mice. Chinese Journal of Biochemical Pharmaceutics, 22, 227-229. (In Chinese)
[17]  Parada, A.E., Needham, D.M. and Fuhrman, J.A. (2016) Every Base Matters: Assessing Small Subunit rRNA Primers for Marine Microbiomes with Mock Communities, Time Series and Global Field Samples. En-vironmental Microbiology, 18, 1403-1414.
[18]  Caporaso, J.G., Kuczynski, J., Stombaugh, et al. (2010) QIIME Allows Analysis of High-Throughput Community Sequencing Data. Nature Methods, 7, 335-336.
[19]  Mago?, T. and Salzberg, S.L. (2011) FLASH: Fast Length Adjustment of Short Reads to Improve Genome Assemblies. Bioinformatics, 27, 2957-2963.
[20]  Price, M.N., Dehal, P.S. and Ar-kin, A.P. (2010) FastTree 2-Approximately Maximum-Likelihood Trees for Large Align-ments. PLoS ONE, 5, e9490.
[21]  Hu, T., Wen, P., Shen, W., Liu, F., Li, Q., Li, E., Liao, S., Wu, H. and Zou, Y. (2019) Effect of 1-Deoxynojirimycin Isolated from Mulberry Leaves on Glucose Metabolism and Gut Mi-crobiota in a Streptozotocin-Induced Diabetic Mouse Model. Journal of Natural Products, 82, 2189-2200.


comments powered by Disqus

Contact Us


微信:OALib Journal